CDI offers products and services that aid the diagnosis of small intestinal bacterial overgrowth (SIBO) and irritable bowel syndrome (IBS).

Health Care

Health Diagnostics

Commonwealth Diagnostics International

Commonwealth Diagnostics International's headquarters in Salem, MA, United States

Craig S. Strasnick

Gray W. Rifkin

Zack Alvarez

Jason Abrahams

Angela Steinhardt

Brennan Spiegel

Anthony Hobson

Carmelo Scarpignato

Evangelos J. Giamarellos-Bourboulis

Jose Maria Remes-Troche

Max J. Schmulson

William Chey

Peter Malfertheiner

The Advisory Team at Commonwealth Diagnostics International provides expert guidance and strategic insights to support the development and optimization of diagnostic products and services for small intestinal bacterial overgrowth (SIBO) and irritable bowel syndrome (IBS). They leverage their specialized knowledge to ensure clinical relevance and efficacy.

Advisory Team

The Leadership Team at Commonwealth Diagnostics International plays a critical role in guiding the company's strategic vision and operational execution. Comprising the President & CEO, COO, CFO, and other key executives, this team collaborates to drive innovation in products and services for diagnosing SIBO and IBS, ensure regulatory compliance, foster growth, and maintain financial health. Their collective expertise supports CDI's commitment to advancing healthcare solutions in gastrointestinal conditions.

Leadership Team

Commonwealth Diagnostics International

Org chart

Board & advisors

Teams

Advisory Team

Leadership Team

Offices

Commonwealth Diagnostics International

Org chart

Board & advisors

Teams

Advisory Team

Leadership Team

Offices

Related companies